Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results[...]
Vontier Reports Strong Third Quarter 2024 Results and Narrows Full Year[...]
Matinas BioPharma Holdings Inc.
Matinas BioPharma Announces the Termination of MAT2203 Partnership[...]
10/31/2024 | Press release | Distributed by Public on 10/31/2024 04:36
Please select the service you want to use:
Smartlinks | InfuSystem Holdings Inc. | News | Health | Company News | Top Company News | Corporate and Financial Calendar | Conference Calls and Webcasts | Securities Issuers | Medical Supplies and Equipment Companies | New York Stock Exchange (NYSE) | Frankfurt Stock Exchange | Stuttgart Stock Exchange | NYSE American | NYSE ARCA Equities | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Investors Exchange (IEX) | Nasdaq BX | Nasdaq Intermarket | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact